You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
MBS has developed a compact endpoint PCR system which can test more than 22,000 patient samples per day by performing eight-minute thermal cycling.
The kit is designed to detect the RdRP gene, E gene, and N gene of the virus and runs on all major thermocyclers.
The MBS NextGenPCR system was distributed by Canon Biomedical in the US until that firm ceased operations early last year.
The company is developing dedicated product lines for next-generation sequencing that incorporate a thermal cycler capable of 35-minute PCR.
Intas Science Imaging Instruments will launch the Dutch biotechnology company's NextGen PCR thermal cycler in the German market.
The newly independent firm will continue to invest in diagnostics by bringing its menu of PCR tests for infectious diseases to the US and other markets, among other objectives.
The exclusive deal includes sales and marketing of a rapid thermal cycler as well as consumable microplates and pipette tips.
Dutch firm Molecular Biology Systems announced new distribution pacts for its ultra-fast thermal cycler in seven countries or regions.
The firm has improved design of the system for low-resource settings and validated it on clinical chlamydia samples and extracted HIV, Ebola, and dengue samples.
The company will showcase the next generation of its Philisa platform, a real-time PCR system which can run four multiplexed qPCR protocols in about 20 minutes.
Researchers have developed a robotic lab assistant, the Verge reports.
CBC News reports Canada's Supreme Court is to rule on the constitutionality of the country's genetic non-discrimination law today.
The Associated Press reports the World Health Organization is sending experts to China to investigate the animal source of SARS-CoV-2.
In Science this week: atlas of affected cell populations in idiopathic pulmonary fibrosis, and more.